Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 2
2024 pubmed 2 citations

Rikkunshito improves anorexia through ghrelin- and orexin-dependent activation of the brain hypothalamus and mesolimbic dopaminergic pathway in rats.

Yakabi. Koji K; Yamaguchi. Naomi N; Takayama. Kiyoshige K; Hosomi. Eriko E; Hori. Yutaro Y; Ro. Shoki S; Ochiai. Mitsuko M; Maezawa. Kosuke K; Yakabi. Seiichi S; Harada. Yumi Y; Fujitsuka. Naoki N; Nagoshi. Sumiko S

Key Findings

  • Rikkunshito restores reduced food intake in stress‑induced anorexia in rats.
  • The appetite‑boosting effect requires activation of the ghrelin receptor, as it is blocked by the antagonist D‑Lys³‑GHRP‑6.
  • Orexin neurons in the hypothalamus also play a crucial role; blocking orexin receptors stops the effect.

Practical Outcomes

  • For biohackers, the study reinforces that stimulating the ghrelin receptor (e.g., with GHRP‑6) can increase appetite, especially under stress. However, the research used a ghrelin antagonist, not GHRP‑6 itself, so it offers no direct dosing guidance. It suggests that combining ghrelin activation with orexin support might be more effective, but further human studies are needed before applying it as a protocol.

Summary

A Japanese herbal mix called Rikkunshito helped stressed rats eat more by turning on brain areas that control hunger. This effect needed the ghrelin receptor (the same one GHRP‑6 works on) and also relied on orexin signals. When a ghrelin‑blocking version of GHRP‑6 was given, the appetite boost disappeared.

Abstract

Rikkunshito (RKT), a traditional Japanese medicine, can relieve epigastric discomfort and anorexia in patients with functional dyspepsia. RKT enhances the orexigenic hormone, ghrelin. Ghrelin regulates food motivation by stimulating the appetite control center in the hypothalamus and the brain mesolimbic dopaminergic pathway (MDPW). However, the effect of RKT on MDPW remains unclear. Here, we aimed to investigate the central neural mechanisms underlying the orexigenic effects of RKT, focusing on the MDPW. We examined the effects of RKT on food intake and neuronal c-Fos expression in restraint stress- and cholecystokinin octapeptide-induced anorexia in male rats. RKT treatment significantly restored stress- and cholecystokinin octapeptide-induced decreased food intake. RKT increased c-Fos expression in the ventral tegmental area (VTA), especially in tyrosine hydroxylase-immunoreactive neurons, and nucleus accumbens (NAc). The effects of RKT were suppressed by the ghrelin receptor antagonist [D-Lys<sup>3</sup>]-GHRP-6. RKT increased the number of c-Fos/orexin-double-positive neurons in the lateral hypothalamus (LH), which project to the VTA. The orexin receptor antagonist, SB334867, suppressed RKT-induced increase in food intake and c-Fos expression in the LH, VTA, and NAc. RKT increased c-Fos expression in the arcuate nucleus and nucleus of the solitary tract of the medulla, which was inhibited by [D-Lys<sup>3</sup>]-GHRP-6. RKT may restore appetite in subjects with anorexia through ghrelin- and orexin-dependent activation of neurons regulating the brain appetite control network, including the hypothalamus and MDPW.

Study Information

Provider

pubmed

Year

2024

Date

2024-08-20T00:00:00.000Z

DOI

10.1111/nmo.14900

Citations

2

References

62